United States Food and Drug Administration. FDA drug safety communication: serious liver disorder associated with the use of Videx/Videx EC (didanosine). January 29, 2010. Available at: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm199169.htm. Accessed August 24, 2018.